A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.

This study is building and testing an artificial intelligence (AI) model to predict outcomes in patients with endometrial (uterine) cancer or hyperplasia (abnormal thickening of the uterine lining). The AI analyzes tissue samples and patient data to identify who is at higher risk for cancer progression. **You may be eligible if...** - You are over 18 years old - You have been diagnosed with endometrial hyperplasia, endometrioid adenocarcinoma of the uterus, or have a healthy uterus and are undergoing hysterectomy for another benign condition - You are willing to provide written consent for the study and use of your data **You may NOT be eligible if...** - You have other active cancers at the same time - You have an infection of the uterine cavity (pyometra) - Your other medical conditions are poorly controlled - Adequate tissue samples or follow-up data are not available Talk to your doctor to see if this trial is right for you.